# Safety and Clinical Performance of a Biological Matrix Used in Abdominal Wall Reconstruction

> **NCT04580511** · — · ACTIVE_NOT_RECRUITING · sponsor: **Meccellis Biotech** · enrollment: 92 (actual)

## Conditions studied

- Abdominal Wall Defect
- Abdominal Wall Injury
- Abdominal Hernia

## Interventions

- **DEVICE:** CELLIS (Porcine Acellular Dermal Matrix, PADM)

## Key facts

- **NCT ID:** NCT04580511
- **Lead sponsor:** Meccellis Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-04
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04580511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04580511, "Safety and Clinical Performance of a Biological Matrix Used in Abdominal Wall Reconstruction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04580511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*